falsefalse

Genomic Testing for Improved Treatments in Breast Cancer - Episode 2

Overview of Genomic Assays for Early-Stage Breast Cancer

,

A comprehensive overview of genomic assays conducted for patients with early-stage breast cancer including MammaPrint, BluePrint, Oncotype DX.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Evolving Treatment Paradigms for Early-Stage Breast Cancers
    Now Viewing
    EP. 2: Overview of Genomic Assays for Early-Stage Breast Cancer
    EP. 3: MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer
    EP. 4: Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer
    EP. 5: FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer
    EP. 6: Exploring Multigene Genomic Assays in High-Risk BC Patients
    EP. 7: Real-World Evidence in Genomic Testing from SABCS 2023
    EP. 8: Racial Disparities and Genomic Testing for Breast Cancer Patients
    EP. 9: Reflecting on Genomic Testing in Practice for Breast Cancer
    EP. 10: Ongoing Studies in Genomic Testing for Breast Cancer

    Related Content:

    Genomic Testing for Improved Treatments in Breast CancerInsightsBreast CancerInsights Video Series
    Vepdegestrant Improves PFS in ESR1-Mutant ER+/HER2– Advanced Breast Cancer
    ASCENT-04 Data Support Sacituzumab Govitecan Plus Pembrolizumab as New SOC in PD-L1+ TNBC
    T-DXd Rechallenge Is Safe After Grade 1 ILD in Breast Cancer and Other Solid Tumors
    x